HomePHAT • NASDAQ
add
Phathom Pharmaceuticals Inc
Previous close
$3.36
Day range
$2.71 - $3.40
Year range
$2.71 - $19.71
Market cap
192.69M USD
Avg Volume
1.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 28.52M | 1,391.58% |
Operating expense | 103.66M | 45.10% |
Net income | -94.32M | -13.84% |
Net profit margin | -330.71 | — |
Earnings per share | -1.07 | 3.60% |
EBITDA | -78.69M | -12.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 212.32M | -34.11% |
Total assets | 294.21M | -17.47% |
Total liabilities | 632.58M | 25.26% |
Total equity | -338.38M | — |
Shares outstanding | 69.81M | — |
Price to book | -0.69 | — |
Return on assets | — | — |
Return on capital | -74.73% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -94.32M | -13.84% |
Cash from operations | -84.93M | -23.05% |
Cash from investing | -18.00K | 55.00% |
Cash from financing | — | — |
Net change in cash | -84.95M | -43.59% |
Free cash flow | -52.90M | 3.66% |
About
Founded
2018
Headquarters
Website
Employees
427
